Accuray has secured approval from the Chinese National Medical Products Administration (NMPA) for its Radixact SynC and CyberKnife S7 systems.
The introduction of the Radixact SynC system marks the first approval in China for Accuray's ClearRT kVCT imaging and Synchrony technology on the Radixact system, and CyberKnife S7 is the company's latest generation CyberKnife platform, according to the firm.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
